Library Catalog
Chat requires JavaScript.
Request

Log in

To request this item, please log in.

You must have an NCSU Libraries or NCSU Unity account to request this item.

Text Email Print RefWorks
List (0)

Your List provides temporary storage and will be cleared after an hour of inactivity.

You can print, email, text, export, or request items from your List.

Cancer chemotherapy and biotherapy : principles and practice
editors Bruce A. Chabner, Dan L. Longo.
 
Location
   
Online
       
Veterinary Medicine Library Call Number
  Stacks RC271 .C5 C32219 2006 (Browse Shelf) Available
Details
Other Authors
Description
  • ISBN: 0781756286 (alk. paper)
  • OCLC Number: 61285522
Notes
  • Includes bibliographical references and index.
Table of Contents

1. Clinical strategies for cancer treatment : the role of drugs / Bruce A. Chabner -- 2. Preclinical aspects of cancer drug discovery and development / Paula Krosky, Melinda Hollingshead, Robert Shoemaker and Edward A. Sausville -- 3. Pharmacokinetics / Jerry Collins and Jeffrey G. Supko -- 4. Infertility after cancer chemotherapy / Angela Bradbury and Richard L. Schilsky -- 5. Carcinogenesis of anticancer drugs / Lawrence S. Blaszkowsky and Charles Erlichman -- 6. Antifolates / Brian P. Monahan and Carmen J. Allegra -- 7. 5-fluoropyrimidines / Jean L. Grem -- 8. Cytidine analogues / David P. Ryan, Rocio Garcia-Carbonero and Bruce A. Chabner --18. Anthracyclines and anthracenediones / James H. Doroshow -- 19. Topoisomerase II inhibitors : the epipodophyllotoxins, acridines, and ellipticines / Yves Pommier and Francois Goldwasser -- 20. Asparaginase / Bruce A. Chabner and Alison M. Friedmann -- 21. Delivering anticancer drugs to brain tumors / Maciej M. Mrugala, Tracy T. Batchelor and Jeffrey C. Supko -- 22. Food and drug administration role in oncology product development / Thomas G. Roberts, Jr. -- 23. Central venous catheters : care and complications / Rachel P. Rosovsky and David J. Kuter -- 24. Pharmacogenetics / Jeanne Fourie and Robert B. Diasio --25. New targets for anticancer therapeutics / A. Dimitrios Colevas, Orit Scharf, Janet E. Dancey, S. Percy Ivy, Len Neckers, Bennett Kaufman and Richard Swerdlow -- 26. Bisphosphonates / Matthew R. Smith -- 27. Thalidomide and its analogs for the treatment of hematologic malignancies, including multiple myeloma, and solid tumors / Paul Richardson, Constantine S. Mitsiades, Teru Hideshima and Kenneth Anderson -- 28. Inhibitors of tumor angiogenesis / Anaadriana Zakarija and William I. Gradishar -- 29. Proteasome inhibitors / Owen A. O'Connor -- 30. Molecular targeted drugs and growth factor receptor inhibitors / Jeffrey W. Clark --31. Antibody therapies of cancer / David A. Scheinberg, Deborah A. Mulford, Joseph G. Juric, Richard P. Junghans and George Sgouros -- 32. Interferons / Daniel J. Lindner, Kevin L. Taylor, Frederic J. Reu, Paul A. Masci and Ernest C. Borden -- 33. Adoptive cellular therapies / Carl H. June -- 34. Cancer vaccines / Glenn Dranoff -- 35. Hematopoietic growth factors / William P. Petros -- 36. Interleukins / Gheath Alatrash, Ronald M. Bukowski, Charles S. Tannenbaum and James H. Finke -- 37. Hormonal therapy for breast cancer / Peter F. Lebowitz and Sandra M. Swain.9. Purine antimetabolites / Kenneth R. Hande -- 10. Hydroxyurea / Luis Paz-Ares, Ross C. Donehower and Bruce A. Chabner -- 11. Antimicrotubule agents / Eric K. Rowinsky -- 12. Clinical and high-dose alkylating agents / Kenneth D. Tew, O. Michael Colvin and Roy B. Jones -- 13. Nonclassic agents / Henry S. Friedman, Steven D. Averbuch and Joanne Kurtzberg -- 14. Cisplatin, carboplatin, and oxaliplatin / Eddie Reed -- 15. Bleomycin / John S. Lazo and Bruce A. Chabner -- 16. Antitumor antibiotics / Edwin W. Willems, Kees Nooter and Jaap Verweij -- 17. Topoisomerase I-targeting drugs / Alex Sparreboom and William C. Zamboni --
History
Preview
MARC